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Intrinsically photosensitive retinal ganglion cells 
(ipRGCs) express the photopigment melanopsin (also known 
as opsin 4, or OPN4) and make up about 1%–3% of the total 
ganglion cell population in the mammalian retina [1]. ipRGCs 
are morphologically diverse with several distinct functions 
[2]. They are primarily responsible for non-image-forming 
tasks such as circadian photoentrainment and the pupillary 
light reflex via projection to the suprachiasmatic nucleus 
(SCN) and olivary pretectal nucleus, respectively [1-3]. Never-
theless, some ipRGCs project to the dorsal lateral geniculate 
nucleus (dLGN) and superior colliculus and may be involved 
in low-acuity pattern vision [2]. Interestingly, ipRGCs have 
been found to be resistant to cell death in various experi-
mental models such as intraocular hypertension [4,5], optic 
nerve transection [5,6], and kainic acid treatment [7]. ipRGCs 
are also less prone to death in the DBA/2J mouse, a model for 
glaucoma [8], and in advanced stages of human neurodegen-
erative ocular diseases due to mitochondrial dysfunction [9]. 
It remains to be investigated whether ipRGCs also survive 
after N-methyl-D-aspartic acid (NMDA)-induced excitotox-
icity, the main experimental approach to induce and study 
ganglion cell death.
NMDA is an agonist at the NMDA receptor, one of three 
ionotropic glutamate receptors [10]. NMDA induces degener-
ation of ganglion and amacrine cells in the ganglion cell layer 
(GCL) and inner nuclear layer (INL) of the retina [11,12], and 
is often used to study molecular mechanisms of ganglion cell 
death and neuroprotection [13]. Since NMDA injury activates 
not only proapoptotic but also antiapoptotic signaling [14], 
this model is also suitable for studying survival mechanisms. 
Detailed characterization of the molecular response after 
NMDA application may thus allow an understanding of 
why some cells die and some cells survive in response to a 
particular stimulus. This seems crucial for comprehending 
the mechanisms of ganglion cell death and eventually treating 
diseases such as glaucoma, the second leading cause of blind-
ness worldwide [15].
The molecular basis for protecting ipRGCs has not been 
identified, but may involve phosphatidylinositol 3-kinase 
(PI3K)/AKT signaling, at least after optic nerve transection 
and ocular hypertension [5]. Another endogenous survival 
signaling pathway that may increase the resistance of ipRGCs 
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Purpose: Intrinsically photosensitive retinal ganglion cells (ipRGCs) express the photopigment melanopsin (OPN4) 
and are mainly responsible for non-image-forming visual tasks such as circadian photoentrainment and the pupillary 
light reflex. Compared to other classes of RGCs, ipRGCs are more resistant to cell death in several experimental models 
such as ocular hypertension, optic nerve transection, and others. Here, we tested whether ipRGCs are also resistant to 
N-methyl-D-aspartic acid (NMDA)-induced excitotoxicity.
Methods: Mice were injected intravitreally with NMDA, and subsequent expression levels of Opn4 and Brn3a mRNA 
were analyzed with semiquantitative real-time PCR. Cells immunopositive for BRN3A and OPN4 were quantified in 
retinal flat mounts of NMDA- and PBS-injected eyes. The molecular response of the retina to NMDA treatment was 
analyzed with real-time PCR and western blotting. Intravitreal injections of wortmannin and AG-490 were used to 
inhibit phosphatidylinositol 3-kinase (PI3K)/AKT and Janus kinase/signal transducers and activators of transcription 
(JAK/STAT) signaling, respectively.
Results: In contrast to retinal Brn3a expression and BRN3A-containing cells, levels of Opn4 mRNA and the number of 
OPN4-expressing cells were not reduced after NMDA injection. Survival of ipRGCs after NMDA injection was not strain 
specific, did not require the presence of photoreceptor cells, and did not depend on PI3K/AKT or JAK/STAT signaling, 
although both signaling pathways were activated after NMDA treatment.
Conclusions: Our data support the existence of an efficient survival system for ipRGCs. This system does not depend 
on PI3K/AKT or JAK/STAT signaling. Identification of the responsible molecular survival mechanisms may provide 
clues to protect “traditional” ganglion cells in diseases such as glaucoma.
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may involve Janus kinase/signal transducer and activator of 
transcription (JAK/STAT) signaling, which has been shown to 
support the survival of various retinal cells against cell death. 
JAK/STAT signaling is activated in response to various inner 
and outer retinal insults such as photoreceptor injury [16], 
increased intraocular pressure [17], and NMDA excitotoxicity 
[18,19]. This signaling is initiated by the binding of cyto-
kines of the interleukin-6 (IL-6) family of proteins to their 
respective transmembrane receptors. Within the IL-6 family, 
leukemia inhibitory factor (LIF) in particular has been found 
to be critical for survival of retinal cells under stress. Photo-
receptor injury induces Lif expression in a subset of Müller 
glial cells, which controls a downstream signaling cascade 
culminating in the increased expression of neuroprotective 
factors such as fibroblast growth factor (FGF2) [16,20-22]. In 
addition, Lif expression is induced after intravitreal injection 
of NMDA in mice [18], and STAT3 activation is protective 
for retinal ganglion cells after glutamate injury in vitro and 
ischemia-reperfusion in vivo [19]. However, whether these 
pathways are involved in protecting ipRGCs is not known.
In this study, we show that ipRGCs are also resistant to 
cell death after intravitreal injection of NMDA in mice and 
present data suggesting that the PI3K/AKT and JAK/STAT 
pathways are not major contributing factors in the enhanced 
survival of ipRGCs in this model.
METHODS
Animals: Animals were treated in accordance with the regula-
tions of the Cantonal Veterinary Authority of Zürich and with 
the Association for Research in Vision and Ophthalmology 
Statement for the Use of Animals in Ophthalmic and Vision 
Research. The 129S6/SvEvTac (129S6) mice (Taconic, 
Hudson, NY), rd10 mice (Jackson Laboratory, Bar Harbor, 
ME), and CD1 mice (Charles River Laboratories, Wilm-
ington, MA) were housed in a 12 h:12 h light-dark cycle with 
access to food and water ad libitum. During the light cycle, 
the light level was maintained at 60 lux.
Intravitreal injections: Injections were always performed 
between 9 and 11 AM to control for circadian variations in 
gene expression levels. Mice were anesthetized with a subcu-
taneous injection (2 μl per gram bodyweight) of a mixture 
of 510 μl ketamine and 60 μl xylazine. Withdrawal response 
to paw pinch was tested after 10 min, and when sufficiently 
immobilized, the animals were prepared for surgery. A 
surgical needle was used to create a sling for the upper eyelid, 
and the cornea and conjunctiva were anesthetized locally with 
oxybuprocaine 0.4% eye drops (Théa Pharma, Schaffhausen, 
Switzerland). A small area of conjunctiva 1 mm distal to 
the limbus was dissected away to reveal the sclera, and a 
sclerostomy was made with a 30-gauge needle. A 30-gauge 
blunt-end needle on a 10 μl Hamilton syringe was then used 
to inject 1 μl of 40 mM NMDA (Sigma-Aldrich, St. Louis, 
MO) in 0.1 M phosphate buffered saline (PBS: 2.622 g of 
NaH2PO4xH2O; 11.5 g Na2HPO4; 8 g NaCl; 0.2 g KCl per 
1000 ml H2O) under light microscopy visualization through 
the pupil. The fellow eye was injected with PBS alone. Alter-
nately, 1 μl of a mixture of 40 mM NMDA / 1 mM wort-
mannin (Sigma-Aldrich) in 10% dimethyl sulfoxide (DMSO, 
Sigma-Aldrich) and PBS or 1 µl of a mixture of 40 mM 
NMDA / 10 mg/ml AG-490 (LC Laboratories, Woburn, MA) 
in 50% DMSO and PBS were coinjected. Here, the fellow 
eye was injected with 40 mM NMDA in 10% DMSO and 
PBS, with 1 mM wortmannin in 10% DMSO and PBS or 
with 10 mg/ml AG-490 in 50% DMSO and PBS, respectively. 
The injection needle was left in place for 20 s before being 
slowly withdrawn. Care was taken to avoid injury to the 
lens or retina. After injection, the cornea was dabbed with a 
cotton swab and coated with a lubricating eye gel (Lacrinorm, 
Bausch and Lomb, Schenkon, Switzerland). Mice recovered 
from anesthesia on a heating pad in dimmed light conditions 
with frequent monitoring and were assessed daily after injec-
tion for signs of infection.
Morphology and quantification of retinal ganglion cells: 
At 6 days post injection, the eyes were enucleated and fixed 
overnight in 4% (w/v) paraformaldehyde in PBS. After a 
washing step with PBS, the eyes were dehydrated in a series 
of increasing ethanol concentrations, washed in xylene, 
and fixed in paraffin. Semithin sagittal sections (500 nm) 
bisecting the optic nerve were prepared and stained with 
hematoxylin and eosin. Sections were analyzed with light 
microscopy, and cell bodies in the ganglion cell layer were 
counted from periphery to periphery in two sections per eye 
and averaged. A total of three eyes (n=3) were analyzed per 
condition. Erythrocytes and endothelial cells were excluded 
from counting.
RNA isolation and semiquantitative real time–polymerase 
chain reaction: Mice were sacrificed at 6 h, 24 h, 48 h, or 6 
days post injection. Retinas were isolated through a corneal 
incision and immediately frozen in liquid nitrogen. Total 
RNA was extracted using an RNA isolation kit (RNeasy; 
Qiagen, Hilden, Germany) including a DNase treatment step. 
Retinas from eyes injected with AG-490 were isolated, and 
RNA and protein were simultaneously prepared from the 
same retina: Retinas were homogenized in 200 µl H2O by 
sonication (10 cycles; 0.3 s ON (30% output) and 0.7 s OFF) 
at 4 °C. Immediately after homogenization, 50 µl were added 
to 450 µl lysis/binding buffer from the High Pure RNA Isola-
tion Kit (Roche Diagnostics, Mannheim, Germany). RNA 
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isolation was performed using the same kit according to the 
manufacturer’s recommendations. 140 µl of the homogenate 
were added to 16 µl of 1M Tris-HCl (pH 7.6), and protein 
concentrations were determined using Bradford reagent and 
a bovine serum albumin standard. Proteins were used for 
western blotting as described below.
Reverse transcription was performed using oligo(dT) 
and M-MLV reverse transcriptase (Promega, Madison, WI). 
Semiquantitative real-time PCR was used to analyze gene 
expression of samples in duplicate or triplicate. This was 
performed with specific primer pairs (Table 1) spanning 
an exon-exon junction in the RNA of the gene in question, 
a polymerase ready mix (LightCycler 480 SYBR Green I 
Master Mix; Roche Diagnostics, Indianapolis, IN), and a 
thermocycler (LightCycler; Roche Diagnostics). Signals 
were normalized to β-actin (Actb) and relative expression 
was calculated with the comparative threshold cycle (ΔΔCT) 
method using a control sample for calibration [23].
Immunofluorescence on sagittal sections: Treated 129S6 
wild-type mice were sacrificed 6 days following injec-
tion. Eyes were enucleated and fixed overnight in 4% (w/v) 
paraformaldehyde in PBS. After the cornea and lens were 
removed, eyecups were postfixed in 4% paraformaldehyde for 
an additional 2 h before being transferred to 30% sucrose in 
0.1 M PBS at 4 °C for 4–12 h. The eyes were then embedded 
in tissue-freezing medium (Leica Microsystems Nussloch 
GmbH, Nussloch, Germany) and frozen in a 2-methylbutane 
bath cooled by liquid nitrogen. Retinal sagittal sections 
(12 µm) were cut, placed on slides, and incubated with a 
blocking solution (3% normal goat serum, 0.3% Triton X-100 
in 0.1 M PBS) for 1 h at room temperature (RT). For protein 
detection, sections were incubated at 4 °C overnight with 
mouse anti-BRN3A (1:100, cat no. MAB1585, Millipore, 
Billerica, MA) diluted in blocking solution. After three 
washes with PBS, slides were incubated with a secondary 
antibody coupled to Cy3 for 1 h at room temperature, washed, 
counterstained with 4’,6-diamidino-2-phenylindole (DAPI), 
and mounted with antifade medium (10% (v/v) Mowiol 4–88; 
Calbiochem, San Diego, CA), in 100 mM Tris (pH 8.5), 25% 
glycerol (w/v), and 0.1% 1,4-diazabicyclo (2.2.2) octane. 
Immunofluorescent staining was analyzed with a digitalized 
microscope (AxioVision; Carl Zeiss Meditec, Dublin, CA).
Western blots: Wild-type 129S6 mice were sacrificed at 6 
h or 24 h following injection and the retinas isolated and 
snap frozen as described above. Retinas were sonified in 
0.1 M Tris/HCl (pH 8.0) and analyzed for protein content 
using Bradford reagent. Protein extracts were mixed with 
sodium dodecylsulfate sample buffer and incubated for 10 
min at 75 °C. Equivalent amounts of proteins were sepa-
rated with sodium dodecylsulfate–polyacrylamide gel 
electrophoresis and transferred to nitrocellulose membranes. 
Membranes were blocked in 5% milk (Bio-Rad, Hercules, 
CA) in TBST (10 mM Tris/HCl [pH 8.0], 150 mM NaCl, and 
0.05% Tween-20) for 1 h at room temperature before being 
incubated overnight at 4 °C in the same 5% milk solution 
containing the respective primary antibody. The primary 
antibodies used were as follows: rabbit anti-STAT3 (1:1000, 
no. 9132, Cell Signaling Technology, Beverly, MA), rabbit 
anti-pSTAT3 (1:500, no. 9131, Cell Signaling Technology), 
rabbit anti-STAT1 (1:1000, no. 9172, Cell Signaling Tech-
nology), rabbit anti-pSTAT1 (1:1000, no. 9171, Cell Signaling 
Technology), rabbit anti-caspase 1 (1:10,000, generous gift 
from Peter Vandenabeele, Ghent University, Belgium), 
Table 1. Primer Pairs used for semiquanTiTaTive real Time PCr
Gene Upstream Downstream Product
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153 bp
Brn3a CGCCGCTGCAGAGCAACCTCTT TGGTACGTGGCGTCCGGCTT 130 bp
Casp1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 138 bp
Clc GCATCAACTCCGCAGCTTAG CTGAACGCCATAGCCAGGTCT 443 bp
Edn2 AGACCTCCTCCGAAAGCTG CTGGCTGTAGCTGGCAAAG 64 bp
Fgf2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG 158 bp
Gfap CCACCAAACTGGCTGATGTCTAC TTCTCTCCAAATCCACACGAGC 240 bp
Gnat1 GAGGATGCTGAGAAGGATGC TGAATGTTGAGCGTGGTCAT 209 bp
Gnat2 GCATCAGTGCTGAGGACAAA CTAGGCACTCTTCGGGTGAG 192 bp
Lif AATGCCACCTGTGCCATACG CAACTTGGTCTTCTCTGTCCCG 216 bp
Mcp-1 GGCTCAGCCAGATGCAGTTA CTGCTGCTGGTGATCCTCTT 108 bp
Opn4 CCAGCTTCACAACCAGTCCT CAGCCTGATGTGCAGATGTC 111 bp
Stat3 CAAAACCCTCAAGAGCCAAGG TCACTCACAATGCTTCTCCGC 139 bp
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mouse anti-glial fibrillary acidic protein (1:500, no. G-3893, 
Sigma-Aldrich), rabbit anti-pAKTSer473 (1:2500, no. 9271, Cell 
Signaling Technology), rabbit anti-AKT (1:2500, no. 9272, 
Cell Signaling Technology), and mouse anti-β-actin (1:5000, 
no. A5441, Sigma-Aldrich). Detection was with horseradish 
peroxidase–conjugated secondary antibodies, and proteins 
were visualized using a detection kit (Western Lightning 
Plus-ECL, PerkinElmer Life Sciences, Boston, MA).
Immunofluorescence and quantification of cells in retinal 
flat mounts: Six days after intravitreal injection, 129S6 wild-
type mice were deeply anesthetized with 200 μl ketamine / 
60 μl xylazine administered intraperitoneally before being 
perfused with 10 ml of PBS followed by 20 ml of 4% parafor-
maldehyde in PBS. Eyes were enucleated, incubated for 5 min 
in 2% paraformaldehyde in PBS, and transferred to PBS. The 
eyes were cut along the ora serrata and the cornea and lens 
were removed. The retina was then dissected from the sclera 
and flattened by making four radial cuts yielding a cloverleaf 
shape [24]. Before immunofluorescence analysis, retinal flat 
mounts were incubated for 1 h (at RT) in 4% paraformal-
dehyde in PBS and blocked with PBS containing 3% fetal 
bovine serum and 0.3% Triton X-100 for 1 h (at RT). They 
were then incubated with the appropriate primary antibodies 
for 48 h: mouse anti-BRN3A (1:100, cat no. MAB1585, Milli-
pore), rabbit anti-OPN4 (1:500, generous gift from Dr. Ignacio 
Provencio, Charlottesville, VA), and mouse anti-NR1 (1:500, 
clone N308/48, NeuroMab c/o Antibodies Inc., Davis, CA). 
Flat mounts were washed 3 times for 10 min each in PBS and 
then incubated for 2 h with the respective secondary antibody 
(anti-mouse-Cy2, anti-rabbit-Cy3, 1:500). They were washed 
again with PBS before being mounted with antifade medium 
(Mowiol 4-88 Reagent, Sigma-Aldrich). Immunofluorescent 
staining was analyzed with a digitalized microscope (AxioVi-
sion, Carl Zeiss Meditec).
Quantification of BRN3A-positive cells was performed 
by counting labeled cells in eight 380 by 610 μm microscopic 
fields per retina. Fields were located at 700 μm and 1700 μm 
from the optic nerve head in each retinal quadrant. The cell 
counts of all eight fields were averaged and extrapolated to 
the number of cells per mm2 using the measured total retina 
area. As there are far fewer OPN4-positive cells in the retina, 
these were quantified by counting the total number of labeled 
cells per whole retina and then converting to cells per mm2 
as above.
Statistical analyses: Statistical analyses were performed 
using Prism4 software. Statistical differences of means were 
calculated using one-way (if three or more experimental 
groups and one variable) or two-way (if two or more vari-
ables) analysis of variance (ANOVA) followed by Bonferroni 
post-hoc testing. A two-tailed unpaired Student t test was 
used only when only two experimental groups and one vari-
able were present. P values less than 0.05 were considered 
significant.
RESULTS
Ganglion cell death after intravitreal injection of N-methyl-
D-aspartic acid: We confirmed loss of cells in the ganglion 
cell layer with light microscopy of sagittal retinal sections 
at 6 days after intravitreal injection of NMDA (Figure 
1A-C), and with immunofluorescence staining for BRN3A 
(Figure 1D-F). BRN3A is a POU-domain transcription factor 
expressed in thalamocortical and collicular projecting RGCs. 
BRN3A is frequently used as an RGC marker, as a decrease 
in Brn3a mRNA levels correlates with loss of ganglion cells 
[25-27]. NMDA-treated retinas showed reduced cell density 
in the GCL (Figure 1G) and probably the INL (not quanti-
fied). No difference was observed between PBS-treated and 
uninjected retinas; they appeared essentially normal. As in 
previously published studies [11,28-30], we observed a loss 
of about two-thirds of cells in the ganglion cell layer after 
NMDA was injected compared to PBS (p<0.001). As already 
shown by others, this effect was dose dependent [11] (data not 
shown). Although we did not differentiate between ganglion 
cells and displaced amacrine cells in the ganglion cell layer, 
NMDA treatment leads to significant loss of both types of 
cells in the inner retina, and a loss of cells in the ganglion 
cell layer strongly correlates with axonal loss in the optic 
nerve [18].
Expression of Opn4 is not affected by N-methyl-D-aspartic 
acid injection: To test the sensitivity of the melanopsin-
expressing subset of ganglion cells to NMDA toxicity, we 
analyzed expression of Brn3a and Opn4 mRNA via semi-
quantitative real-time PCR in wild-type mice at 6 h, 24 h, 48 
h, and 6 days after intravitreal injection of NMDA (Figure 
2). As expected, expression of Brn3a was strongly reduced 
starting at 24 h after treatment. Although apoptosis starts 
as early as 6 h after NMDA injection [28], the decrease in 
Brn3a mRNA expression at this early time point was not yet 
statistically significant. In contrast to Brn3a, levels of Opn4 
mRNA were unchanged at all four time points after NMDA 
injection, suggesting either that Opn4-expressing RGCs were 
resistant against NMDA toxicity or that the surviving cells 
increased expression as a compensatory reaction. Since Opn4 
is expressed in a circadian pattern [31,32], NMDA-treated and 
control mice of a particular time group were always treated in 
parallel and analyzed at the same time of day.
OPN4-positive ganglion cells are resistant to N-methyl-D-
aspartic acid–induced excitotoxic cell death: To distinguish 
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between resistance against NMDA toxicity and a compensa-
tory upregulation of Opn4 in surviving RGCs, we costained 
f lat mounted retinas of NMDA- and PBS-injected mice 
for BRN3A and OPN4 (Figure 3A-H). We observed mark-
edly fewer BRN3A-positive cells in NMDA-treated retinas 
(Figure 3A,C,G) compared to the control retinas (Figure 
3B,D,H), but no obvious difference in the number of OPN4-
positive cells between the two treatment groups (Figure 
3A,E,G,B,F,H). Quantification of BRN3A- and OPN4-posi-
tive cells confirmed the mRNA expression data, showing a 
significantly reduced number of BRN3A-positive cells in the 
retinas of the NMDA-treated mice (1188±834.6 cells/mm2 
Figure 1. Cells in the ganglion cell layer are lost after intravitreal injection of N-methyl-D-aspartic acid. A-C: Shown are representative 
photomicrographs of retinal sections from wild type mice 6 days after intravitreal injection of A: N-methyl-D-aspartic acid (NMDA) or 
B: phosphate buffered saline (PBS). C: Untreated retinas served as controls. D-F: Shown are representative photomicrographs of immun-
fluorescent stainings for BRN3A (yellow) and DAPI (blue) in semithin sagittal sections through retinas 6 days after injection of D: NMDA 
or E: PBS. F: Uninjected eyes served as controls. Note the non-specific staining of blood vessels by the secondary antibody, especially in 
the outer plexiform layer (OPL), inner nuclear layer (INL), and inner plexiform layer (IPL). G: Cell bodies in the ganglion cell layer (GCL) 
were quantified at 6 days after intravitreal injection of NMDA (black bar) or PBS (grey bar), and in untreated eyes (white bar). Shown are 
means±SD (n=3) for all treatments and analyses. Scale bars were A-C: 20 µm, D-F: 50 µm. **: p<0.01. A one-way ANOVA with Bonferroni 
post hoc test was used to test statistical significance.
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for NMDA versus 2567±306 cells/mm2 for PBS; mean±SD; 
Figure 3I) while the number of OPN4-positive cells did not 
change (37.1±2.3 cells/mm2 for NMDA versus 35.5±3.3 cells/
mm2 for PBS; Figure 3J). Thus, Opn4 RNA levels were main-
tained after NMDA treatment not because of a compensatory 
upregulation of gene expression but because of the resistance 
of OPN4-positive ipRGCs to NMDA excitotoxicity.
Intrinsically photosensitive retinal ganglion cell resistance to 
N-methyl-D-aspartic acid toxicity is independent of genetic 
background, pigmentation, and the presence of photoreceptor 
cells: To determine whether the survival of OPN4-positive 
ipRGCs after NMDA treatment was a phenomenon isolated 
to the particular strain of wild-type mice used (129S6), we 
also analyzed Brn3a and Opn4 expression in NMDA-treated 
albino CD1 mice. Again, NMDA treatment significantly 
reduced Brn3a but not Opn4 expression (Figure 4A). This 
observation suggests that the survival of ipRGCs after 
NMDA is a general phenomenon and is not due to differences 
in pigmentation or genetic background.
To determine whether ipRGC resistance to NMDA 
toxicity depended on the presence of regulated glutamate 
release from bipolar cells and thus on phototransduction-initi-
ated signaling from photoreceptor cells, we injected NMDA 
in rd10 mice. The rd10 mouse carries a missense mutation 
in exon 13 of the β-subunit of cyclic guanosine monophos-
phate phosphodiesterase, and exhibits degeneration of rod 
and cone photoreceptors beginning at PND16 with almost 
complete degeneration by PND60 [33]. We injected the eyes 
of rd10 mice at PND20 when the retinas contained functional 
photoreceptors and at 6 months of age, when the rd10 mice 
had virtually no photoreceptor function left. We confirmed 
degeneration of photoreceptors with semiquantitative real-
time PCR for rod (Gnat1) and cone (Gnat2) transducin, which 
were expressed at the expected levels [34] in each age group 
(data not shown). Six days after injection, we compared Brn3a 
and Opn4 expression in young and old rd10 mice. As in the 
wild-type mice, we observed a significant reduction in Brn3a 
but not Opn4 mRNA expression in both age groups (Figure 
4B,C). This suggests that neither NMDA-induced toxicity to 
“traditional” ganglion cells nor survival of ipRGCs depended 
on signaling from photoreceptor cells.
Endogenous rescue and stress pathways are activated after 
intravitreal N-methyl-D-aspartic acid injection: The JAK/
STAT pathway is an endogenous survival signaling pathway 
activated in response to various inner and outer retinal insults 
such as photoreceptor injury [16,35] and ganglion cell death 
after intraocular hypertension [17]. To test a potential role of 
this signaling mechanism in NMDA-induced excitotoxicity, 
we analyzed the mRNA levels of several members of the 
JAK/STAT pathway at various time points after intravitreal 
NMDA injection (Figure 5A). We found that the Lif and 
Clc mRNA levels were significantly increased by a factor 
of 5 and 3.5, respectively, at 6 h after injection. Edn2 and 
Fgf2 mRNA expression peaked at 24 h, with approximately 
ten- and threefold greater expression levels compared to the 
PBS-injected retinas. This was followed by an increase in 
Stat3 and Gfap expression, which peaked at 48 h. STAT3 
is known to have antiapoptotic effects via activation of the 
suppressor of cytokine signaling (SOCS) family of proteins 
and the Bcl-2 family [19]. Glial fibrillary acidic protein (Gfap) 
is a marker for activated Müller glial cells. Several genes 
encoding proapoptotic proteins also increased expression 
after NMDA injection: Levels of Stat1 mRNA were signifi-
cantly increased at 24 h, and caspase-1 (Casp-1) mRNA was 
threefold and fourfold elevated compared to controls at 24 
h and 48 h, respectively. In contrast, monocyte chemotactic 
protein-1 (Mcp-1), a cytokine involved in recruiting white 
blood cells to sites of infection or inflammation [36], was 
Figure 2. Expression of Opn4 is not 
affected by N-methyl-D-aspartic 
acid injection. Shown are the rela-
tive expression levels of Brn3a and 
Opn4 in retinas of wild type mice 
at 6 h, 24 h, 48 h, and 6 days after 
injection of N-methyl-D-aspartic 
acid (NMDA, black bars) or phos-
phate buffered saline (PBS, grey 
bars). Expression after NMDA 
injection was expressed relative to 
expression after PBS injection, which was set to 1 for each time point. Shown are means±SD of n=4-6. *; p<0.05; ***; p<0.001. A two-way 
ANOVA with Bonferroni post hoc test was used to test statistical significance.
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Figure 3. N-methyl-D-aspartic acid 
treatment does not reduce survival 
of OPN4-positive ganglion cells. 
Shown are representative photo-
micrographs taken from retinal 
flat mounts stained for BRNA3A 
(yellow) and OPN4 (green) at 6 
days after A, C, E, G: N-methyl-
D-aspartic acid (NMDA) injec-
tion or B, D, F, H: phosphate 
buffered saline (PBS) injection. 
A, B: Shown is double labeling for 
BRN3A and OPN4. C, D: Shown 
is BRN3A staining. E, F: Shown 
is OPN4 staining. G, H: Shown 
are merges of panels C and E, or 
D and F, respectively, n=3-4. Scale 
bars are A, B: 100 µm; C-H: 50 
µm. I-J: Shown is quantification 
of I: BRN3A- positive cells and 
J: OPN4-positive cells in retinal 
flat mounts at 6 days after NMDA 
(black bars) or PBS (grey bars) 
treatment. Shown are means±SD 
of n=3-4. *; p<0.05. An unpaired 
two-tailed Student t test was used 
to test statistical significance.
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similarly expressed in the NMDA- and PBS-treated retinas, 
even though a tendency for increased expression was detected 
in NMDA retinas at 24 h after injection.
Activation of some of these molecules after NMDA 
injection was also detectable at the protein level with western 
blotting (Figure 5B). At 24 h after injection, we found 
strongly elevated levels of phospho-STAT3, STAT3, phospho-
STAT1, and STAT1 in the NMDA-treated retinas compared 
to the PBS-injected controls. In addition, expression of glial 
fibrillary acidic protein and the proform of CASP1 was also 
increased, although somewhat less robustly than the proteins 
mentioned above.
Intrinsically photosensitive retinal ganglion cell survival 
after N-methyl-D-aspartic acid injection is independent 
of phosphatidylinositol 3-kinase/AKT or STAT3 signaling: 
In models of optic nerve transection and ocular hyperten-
sion, the PI3K/AKT pathway was implicated in enhanced 
survival of ipRGCs [5]. To test whether this pathway may 
also contribute to the resistance of ipRGCs against NMDA 
toxicity, we coinjected NMDA with wortmannin (WM), an 
inhibitor of PI3Ks, and compared the mRNA levels of Brn3a 
and Opn4 to retinas treated with NMDA or WM alone (Figure 
6A). Although Brn3a levels were decreased with NMDA and 
NMDA plus WM injections as expected, Opn4 remained 
at control levels even in the presence of the inhibitor. To 
confirm the inhibitory action of WM on AKT activation, we 
tested levels of p-AKTSer473 with western blotting. At 6 h after 
injection, p-AKTSer473 levels were high in NMDA (as previ-
ously established [14]), but not in NMDA plus WM injected 
retinas, indicating that the inhibitor did indeed function as 
expected (Figure 6B).
Injection of NMDA activated JAK/STAT signaling 
in the retina (Figure 5), and expression of a constitutively 
active form of STAT3 protected retinal ganglion cells 
against ischemia reperfusion in vivo and glutamate toxicity 
in vitro [19]. We coinjected eyes with NMDA and AG-490, 
an inhibitor of JAK2, to test whether activation of the JAK/
STAT pathway is essential for ipRGC survival in vivo. Coin-
jection of NMDA with AG-490 reduced phosphorylation of 
STAT3 compared to injection of NMDA alone suggesting 
that AG-490 inhibited JAK2 signaling (Figure 6D). However, 
inhibition of JAK2 did not influence expression of Brn3a and 
Opn4 after NMDA injection as indicated by the respective 
RNA levels at 48 h after injection (Figure 6C).
In summary, these results suggest that PI3K/AKT and 
STAT3 signaling may not be crucial factors in the survival 
of ipRGCs after NMDA injection.
To verify expression of NMDA receptors on ipRGCs, 
we treated retinal f lat mounts of wild-type mice with 
anti-NMDAR1 and anti-OPN4 antibodies and analyzed 
the resulting staining in the GCL. NMDAR1 was widely 
expressed in cell bodies but not the nuclei of the cells in the 
GCL (Figure 7A,D). As shown before (Figure 3), OPN4-
positive cells were rare but easily detectable (Figure 7B,E). 
Merged images suggest that OPN4-positive cells also express 
NMDAR1 subunits (Figure 7C,F).
DISCUSSION
A growing body of evidence suggests that ipRGCs have a 
generally increased survival rate in various experimental 
models of ganglion cell death [4-8,37], as well as in human 
mitochondrial optic neuropathies [9]. Here we demonstrate 
that ipRGCs are also resistant to NMDA-induced excito-
toxicity, and that their resistance does not depend on PI3K/
AKT or JAK/STAT signaling. The survival of ipRGCs after 
various insults is intriguing, and identifying the molecular 
mechanism(s) responsible for their protection might provide 
Figure 4. Resistance of OPN4-
positive cells against N-methyl-
D-aspartic acid toxicity does not 
depend on genetic background, 
pigmentation or presence of photo-
receptor cells. A: Shown is the 
relative expression of Brn3a and 
Opn4 mRNAs in retinas of 6 week 
old albinotic CD1 wild type mice at 6 days after injection of N-methyl-D-aspartic acid (NMDA, black bars) or phosphate buffered saline 
(PBS, grey bars). B: Shown is the relative expression of Brn3a and Opn4 at 6 days after injection of NMDA (black bars) or PBS (grey bars) 
in rd10 mice at 20 days of age. C: Shown is the relative expression of Brn3a and Opn4 at 6 days after injection of NMDA (black bars) or 
PBS (grey bars) in rd10 mice at 6 months of age. Gene expression after NMDA injection was expressed relative to expression after PBS 
injection, which was set to 1. Shown are means±SD of n=4-10. *: p<0.05; **: p<0.01; ***: p<0.001. Statistical tests used were A: unpaired 
two-tailed Student t test, and B-C: two-way ANOVA with Bonferroni post hoc test.
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the knowledge necessary to preserve ganglion cells in human 
diseases such as glaucoma.
The mechanism for NMDA excitotoxicity involves 
activating the NMDA receptor, which results in an influx of 
Figure 5. Intravitreal N-methyl-D-aspartic acid injection activates endogenous rescue and stress pathways. A: Shown is the relative expres-
sion of Lif, Clc, Edn2, Fgf2, Stat1, Stat3, Gfap, Casp1, and Mcp-1 in retinas of 129S6 wild type mice at 6 h, 24 h, 48 h, and 6 days after 
injection of N-methyl-D-aspartic acid (NMDA, black bars) or phosphate buffered saline (PBS, grey bars). Expression after NMDA injection 
was expressed relative to expression after PBS injection, which was set to 1 for each time point. Shown are means±SD of n=4-6. *: p<0.05; 
**: p<0.01; ***: p<0.001. Two-way ANOVA with Bonferroni post hoc test was used to test statistical significance. B: Levels of proteins and 
phosphoproteins in total retinal extracts from 129S6 wild type mice were tested by Western Blotting at 24 h after injection of NMDA or 
PBS. Shown are protein levels in extracts of two retinas after NMDA and two retinas after PBS injection as indicated, n=3.
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calcium into the cell, triggering various signaling cascades resulting in apoptotic cell death [30,38,39]. Lack of the 
Figure 6. Survival of OPN4-expressing intrinsically photosensitive retinal ganglion cells does not depend on phosphatidylinositol 3-kinase/
AKT and Janus kinase/signal transducer and activator of transcription signaling. A: Shown is the relative expression of Brn3a and Opn4 in 
retinas of 129S6 wild type mice at 24 h after injection of N-methyl-D-aspartic acid (NMDA, black bars), NMDA plus wortmannin (WM, 
grey bars), or WM (white bars). Shown are means±SD of n=4-8. **: p<0.01. One-way ANOVA with Bonferroni post hoc test was used to 
test statistical significance. B: Shown are levels of proteins and phosphoproteins in total retinal extracts from 129S6 wild type mice at 6 h 
after injection of NMDA or NMDA plus WM as indicated, n=3. C: Shown is the relative expression of Brn3a and Opn4 in retinas of 129S6 
wild type mice at 48 h after injection of NMDA in 50% DMSO (black bars), NMDA plus AG-490 in 50% DMSO (grey bars), or non-injected 
controls (white bars). Shown are means±SD of n=4. ***: p<0.001. One-way ANOVA with Bonferroni post hoc test was used to test statistical 
significance. D: Shown are levels of STAT3 and pSTAT3 in total retinal extracts from 129S6 wild type mice at 48 h after injection of NMDA 
or NMDA plus AG-490 as indicated. C: RNA and D: proteins were simultaneously isolated from the same retinas for analysis, n=4.
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NMDA receptor might therefore be a possible explanation 
for the resistance of ipRGCs to NMDA toxicity. However, 
several studies including this one (Figure 7) have shown that 
ipRGCs express glutamate receptors, and single cell PCR 
data specifically indicates expression of NMDA receptors by 
ipRGCs [3,40,41]. This suggests that the observed resistance 
of ipRGCs is based on another mechanism. The calcium 
permeability of NMDA receptors is reduced when the tripar-
tite receptor complex interacts with NR3A, a subtype of the 
NR3 component of the receptor [10,42]. Accordingly, lack of 
NR3A increased susceptibility of RGCs to NMDA toxicity at 
lower NMDA concentrations of up to 2 nmol [42]. Although 
the effect was lost at higher NMDA levels [42], it would be 
interesting to analyze ipRGC survival in NR3A knockouts, 
especially since Jakobs and coworkers reported expression 
of NR3A by ipRGCs [41]. Whether increased expression of 
NR3A and/or reduced expression of other NMDA receptor 
subunits contributes to protecting ipRGCs against NMDA 
toxicity must be conclusively shown. However, since such 
a mechanism may not explain the increased resistance of 
ipRGCs across the many other models of ganglion cell death 
(see above), it seems more likely that ipRGCs have developed 
other mechanisms for their protection against degeneration.
Several such mechanisms have been suggested to 
explain the greater robustness of ipRGCs. Li and coworkers, 
for example, implicated the PI3K/AKT pathway in ipRGC 
survival after optic nerve transection and in a model of 
intraocular hypertension [5]. However, injection of wort-
mannin strongly reduced AKT phosphorylation after NMDA 
application but did not reduce survival of ipRGCs (Figure 6) 
suggesting that AKT signaling is not the main component of 
ipRGC resistance against NMDA toxicity.
Other published data point to an involvement of pituitary 
adenylate cyclase activating polypeptide (PACAP), a peptide 
found specifically in ipRGCs of the retinohypothalamic tract 
[37,43]. Exogenous administration of PACAP has been shown 
to be neuroprotective for “traditional” ganglion cells after 
optic nerve transection [44], intraocular hypertension [45], 
kainic acid treatment [46], and NMDA application [28]. Inter-
estingly, exogenous administration of PACAP stimulates IL-6 
production by Müller cells in the retina in vitro and in vivo 
[47]. IL-6 is a known activator of the JAK/STAT pathway, 
which may confer protection for photoreceptors and ganglion 
cells [16,17,21]. Several members of this endogenous rescue 
pathway were activated in response to NMDA injection. 
As reported by others [19], we observed strongly increased 
Figure 7. NMDAR1 colocalizes with OPN4 in retinal ganglion cells. Shown are representative photomicrographs taken from retinal flat 
mounts of untreated wild type mice stained for A, D: NMDAR1 (green) and B, E: OPN4 (red) at A-C: lower and D-F: higher magnification. 
C, F: Images shown in panels A and B, and in panels D and E, respectively, are merged. Focal plane was at the ganglion cell layer. Scale 
bars are A-C: 100 µm and D-F: 50 µm.
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phosphorylation of STAT3 after NMDA application. In addi-
tion, Lif was expressed very early, followed by Edn2 and Fgf2 
(Figure 5), which is similar to models of photoreceptor injury 
[16,35]. Thus, a signaling mechanism involving Müller glial 
cells may be activated not only by photoreceptor degenera-
tion but also after NMDA injection. However, blocking JAK/
STAT signaling by the application of AG-490 did not reduce 
survival of ipRGCs after NMDA treatment. Since we also 
observed elevated levels of proapoptotic proteins such as 
pSTAT1 and CASP1, NMDA administration activated pro- 
and antiapoptotic signaling [14]. The nature of the cells that 
activated the individual signaling pathways still need to be 
determined in future experiments.
Although RGCs and ipRGCs receive signaling input 
from rods and cones via synaptic contacts with bipolar and 
amacrine cells [1,48], survival of ganglion cells is mostly not 
affected in models of photoreceptor degeneration. However, 
some species differences seem to exist regarding Opn4 
expression in the absence of photoreceptors. Studies in RCS 
rats suggest reduced Opn4 levels despite constant numbers of 
ipRGCs in the degenerated retina [32]. In addition, N-methyl-
N-nitrosourea (MNU) treatment reduced expression of 
Opn4 by 83%, whereas only about one-third of melanopsin-
expressing cells were lost after MNU injection [49]. Although 
MNU primarily induces degeneration of photoreceptors, 
whether this loss of ipRGCs was a direct consequence of 
MNU or was indirectly caused by photoreceptor degeneration 
remains to be shown. In contrast, retinas of rod- and cone-
less [50,51] as well as of rd10 mice (data not shown) show 
expression of Opn4 similar to wild-type mice. Thus, ipRGCs 
in mice may not be directly influenced by phototransduction-
related signaling from photoreceptors and/or regulated gluta-
mate release from second-order neurons. Our data from old 
rd10 mice support this conclusion and show that survival of 
ipRGCs after NMDA treatment does not depend on normal 
retinal physiology and photoreceptor function.
In conclusion, ipRGCs are functionally and morpho-
logically different from “traditional” ganglion cells in that 
ipRGCs survive high concentrations of intravitreal NMDA. 
This survival does not depend on PI3K/AKT or JAK/STAT 
signaling. Clearly, ipRGCs have an intrinsic strength to 
survive various insults toxic to “traditional” RGCs. Iden-
tifying the mechanisms conferring this increased survival 
competence may prove highly valuable to define strategies 
for protecting ganglion cells by exogenous approaches.
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